Diagnosis reviewed at transplant center and confirmed to fit the criterion for high risk blood disease or cancer, as defined for the study 
Estimated life expectancy of at least 6 weeks following study entry 
Cancer and Leukemia Group B (CALGB) performance status less than or equal to 2 
White blood cell count, platelet, hematocrit, tuberculosis, aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase, creatinine, and HIV test results reviewed by transplant center 
Multiple gated acquisition (MUGA), echocardiogram, cardiac MRI, and/or pulmonary function tests (PFT) performed and reviewed by transplant center (for individuals with an ejection fraction and diffusing capacity [DLCO] of 40-50%, the appropriate cardiology or pulmonary consultations should be considered if the individual has severe heart or lung disease at the initiation of therapy) 
Sufficient number of umbilical cord blood units available for transplantation 
If female, willing to use contraception throughout the study 

NCT00312429_inc_T1
Condition
high risk blood disease
NCT00312429_inc_T2
Condition
cancer
NCT00312429_inc_T3
Measurement
Estimated life expectancy
NCT00312429_inc_T4
Value
at least 6 weeks following study entry
NCT00312429_inc_T5
Measurement
Cancer and Leukemia Group B (CALGB) performance status
NCT00312429_inc_T8
Value
less than or equal to 2
NCT00312429_inc_T9
Measurement
White blood cell count
NCT00312429_inc_T10
Measurement
platelet
NCT00312429_inc_T11
Measurement
hematocrit
NCT00312429_inc_T12
Measurement
tuberculosis
NCT00312429_inc_T13
Measurement
aspartate aminotransferase (AST)
NCT00312429_inc_T6
Measurement
alanine aminotransferase (ALT)
NCT00312429_inc_T7
Measurement
alkaline phosphatase
NCT00312429_inc_T14
Measurement
creatinine
NCT00312429_inc_T15
Measurement
HIV test results
NCT00312429_inc_T16
Qualifier
reviewed by transplant center
NCT00312429_inc_T17
Scope
White blood cell count, platelet, hematocrit, tuberculosis, aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase, creatinine, and HIV test results
NCT00312429_inc_T18
Procedure
Multiple gated acquisition (MUGA)
NCT00312429_inc_T19
Procedure
echocardiogram
NCT00312429_inc_T20
Procedure
cardiac MRI
NCT00312429_inc_T21
Procedure
pulmonary function tests (PFT)
NCT00312429_inc_T22
Qualifier
reviewed by transplant center
NCT00312429_inc_T23
Scope
Multiple gated acquisition (MUGA), echocardiogram, cardiac MRI, and/or pulmonary function tests (PFT)
NCT00312429_inc_T24
Person
female
NCT00312429_inc_T25
Procedure
contraception
NCT00312429_inc_T26
Temporal
throughout the study
NCT00312429_inc_T27
Measurement
umbilical cord blood units available
NCT00312429_inc_T28
Value
Sufficient number
NCT00312429_inc_T29
Qualifier
for transplantation
NCT00312429_inc_T30
Procedure
transplantation